Cargando…
Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance
MKT-077, a rhodacyanine dye, was shown to produce cancer specific cell death. However, complications prevented the use of this compound beyond clinical trials. Here we describe YM-1, a derivative of MKT-077. We found that YM-1 was more cytotoxic and localized differently than MKT-077. YM-1 demonstra...
Autores principales: | Koren, John, Miyata, Yoshinari, Kiray, Janine, O'Leary, John C., Nguyen, Lana, Guo, Jianping, Blair, Laura J., Li, Xiokai, Jinwal, Umesh K., Cheng, Jin Q., Gestwicki, Jason E., Dickey, Chad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338522/ https://www.ncbi.nlm.nih.gov/pubmed/22563386 http://dx.doi.org/10.1371/journal.pone.0035566 |
Ejemplares similares
-
Correction: Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance
por: Koren, John, et al.
Publicado: (2012) -
Exploiting the Diversity of the Heat-Shock Protein Family for Primary and Secondary Tauopathy Therapeutics
por: Abisambra, Jose F, et al.
Publicado: (2011) -
Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
por: O'Leary, John C, et al.
Publicado: (2010) -
A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51
por: O'Leary, John C., et al.
Publicado: (2011) -
Chaperone signalling complexes in Alzheimer's disease
por: Koren, John, et al.
Publicado: (2009)